About the Webconference
The prevalence of atrial fibrillation (a-fib) is expected to grow to nearly 16 million by 2050, with a price tag of $26 billion per year. With no cure-all treatment option, a-fib patients often seek care from multiple specialists and require long-term management.
A sizeable market and significant improvements in catheter ablation technology in recent years have made a-fib a prime opportunity for many CV programs. However, the decision to pursue the a-fib opportunity requires a concerted approach to generate referrals, coordinate longitudinal care, and foster multidisciplinary practice.
This presentation provides structural and operational guidance on optimizing atrial fibrillation centers, including profiles from progressive programs.
Presenter: Carly Anderson